Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug ...
In August 2022 the Department of Health and Human Services (HHS) issued a notice of proposed rulemaking prohibiting covered entities, which include health care providers and health plans, from ...